Noninvasive assessment of intracranial perfusion in acute cerebral ischemia.
Single-photon emission computed tomography (SPECT) and transcranial Doppler sonography (TCD) may help to determine a target group of patients with maximum therapeutic response for tissue rescue after acute stroke. As previously described, the cerebral perfusion index represents a combination of these techniques, and is calculated by multiplying assigned values for TCD and SPECT perfusion patterns. The three grades of cerebral perfusion index (1-5, 6-12, 15-20) may predict short-term outcome if the index is based on SPECT and TCD performed within the first 6 hours after stroke. A total of 30 consecutive patients were studied (18 with middle cerebral artery stroke and 12 with transient ischemic attack or minor stroke). Neurological deficit was scored using the Canadian Neurological Scale. SPECT and TCD were performed 4 +/- 2 hours after the onset. Forty-five minutes were required to perform both tests, evaluate the results, and calculate the cerebral perfusion index. The mean score (+/- standard deviation) of the neurological deficit on admission was 84 +/- 20 in patients with transient ischemic attack/minor stroke and 54 +/- 33 in patients with stroke (p < 0.009). The volume of ischemic lesion was measured on computed tomography scans performed more than 3 days after the ictus. Patients with transient ischemic attack/minor stroke had lesion volumes of 8 +/- 7 cm3 compared to 72 +/- 26 cm3 for those with stroke (p < 0.0001). The mean cerebral perfusion index in the transient ischemic attack group was 18 +/- 4, while in the stroke group it was 4 +/- 1 (p < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
Alexandrov
A V
AV
Stroke Research Unit University of Toronto, Ontario, Canada.
Bladin
C F
CF
Ehrlich
L E
LE
Norris
J W
JW
D000208:Acute Disease; D000368:Aged; D002545:Brain Ischemia / Q000000981:diagnostic imaging / Q000503:physiopathology*; D002544:Cerebral Infarction / Q000000981:diagnostic imaging / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology*; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000503:physiopathology; D004453:Echoencephalography; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000000981:diagnostic imaging / Q000503:physiopathology; D008297:Male; D009460:Neurologic Examination; D015609:Organotechnetium Compounds; D010091:Oximes; D011446:Prospective Studies; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed; D017585:Ultrasonography, Doppler, Transcranial
D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime